Oak HC/FT

Annie Lamont has been investing in healthcare companies for longer than most of her peers in the sector have been paying attention. Before co-founding Oak HC/FT in 2014 with Patricia Kemp and Andrew Adams, she spent twenty-eight years at Oak Investment Partners, leading its healthcare and fintech practices and investing in companies including athenahealth, CareBridge, Devoted Health, NetSpend, OneMedical, and VillageMD — names that, in retrospect, read like a roadmap of where both industries were going before most investors understood the direction. Her decision to launch a focused successor firm, rather than continue within a more generalist platform, was a deliberate bet that the convergence of healthcare and financial services technology represented a category large enough and specialized enough to warrant its own institution.

That bet has been validated at a scale that requires no hedging. Oak HC/FT manages $5.3 billion in assets across funds that have invested in every stage from seed to growth, generating 46 realizations and 35 portfolio companies achieving valuations in excess of one billion dollars. The firm's investment universe spans healthcare information and services on one axis, and financial services technology on the other — two sectors that Lamont, Kemp, and Adams describe as "uniquely complementary and high-growth," a characterization that the convergence of digital health payment infrastructure, insurance technology, and embedded financial services has made increasingly difficult to dispute.

Annie Lamont's public profile in both industries reflects the accumulated institutional credibility of that thirty-year career: Forbes Midas List, Fortune's Top 20 Private Equity Power Players, Barron's 100 Most Influential Women in U.S. Finance, Modern Healthcare's 100 Most Influential People. She is the first recipient of the National Venture Capital Association's award for Excellence in Healthcare Innovation, and served on the Board of Trustees of Stanford University. She currently sits on the Board of Directors of Bloomberg Inc. These are not honorary distinctions. They are the measured consequence of a career spent understanding how healthcare and financial services actually change, and backing the companies that are doing the changing.